Q2 2026 saw strong acute care volume rebound and steady behavioral health trends, with adjusted EPS up 12% and EBITDA less NCI up 5% year-over-year. Guidance was revised downward due to liability reserves and slower facility ramp-ups, but demand and capital deployment remain robust.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.